Description générale
Deferoxamine is an iron chelating agent used in the treatment of iron overload, acute iron toxicity and in the management of sickle cell disease.
INN
Deferoxamine
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 1979
(TRS
641)
pour
Harmful effects of drugs, medicaments or biological substances, not elsewhere classified
Ajouté en 2011
(TRS
965)
pour
Other specified sickle cell disorders or other haemoglobinopathies
Ajouté en 2023
(TRS
1049)
pour
Thalassaemias
Wikipédia
DrugBank
Recommandations
Section
Antidotes and other substances used in poisonings > Specific
- Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)
Section
Other medicines for haemoglobinopathies
- Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)